Specimens of cerebrospinal fluid (CSF) were obtained from active MS patients and CXCL10 exhibited a higher level than those from the patients with non-inflammatory symptoms, according to the report of Sørensen et al. [57]. Here, CXCL10 is linked to myeloid sarcoma.